Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01039324 · ClinicalTrials.gov registry record · NA
Care Transitions for Complex Patient - Cycle 1 and Cycle 2
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 8,422
- Enrollment target
NCT01039324: Completed NA study, sponsored by Duke University.
NCT01039324 is a NA study that has completed, run by Duke University. The registered enrollment target is 8,422 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (500% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01039324, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8,422 participants
- Enrollment target
Study Summary
The purpose of this study is to improve patient care and safety while decreasing ED visit rates by sending specific information about care transitions related to hospital admission and discharge and emergency department and specialty care visits to primary care practices, care managers and patients with the use of health information technology (HIT) shared across a community-based network of providers. Cycle 1 focuses on the impact of notices about ED encounters and hospitalizations derived from billing data that are sent to care managers for all 47,000 patients in the Northern Piedmont Community Care Network (NPCCN). Cycle 2 explores the impact of letters sent to patients, and care event reports sent to a patient's medical home in addition to notices sent to care managers about ED encounters, hospitalization and specialty care based on ADT (Admission Discharge Transfer) and billing data on 4,600 patients with complex health needs.
Interventions
- OTHER Usual care
- OTHER Reports
- OTHER Reports and Notices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,422 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-09 |
| Phase | NA |
What the finished NCT01039324 record still lists
NCT01039324 is an interventional study that assigns participants to a tested intervention. Its 8,422 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (500% higher).
The record links to 0 conditions, and to 3 interventions - of which Usual care is the first listed.
NCT01039324 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01039324 about?
NCT01039324 is a clinical study titled "Care Transitions for Complex Patient - Cycle 1 and Cycle 2". The purpose of this study is to improve patient care and safety while decreasing ED visit rates by sending specific information about care transitions related to hospital admission and discharge and emergency department and specialty care visits to primary care practices, care managers and patients ...
What is the current status of trial NCT01039324?
This trial is currently completed. It is a NA study. The enrollment target is 8,422 participants. The study started on 2009-12. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01039324?
The interventions under investigation include: Usual care (OTHER), Reports (OTHER), Reports and Notices (OTHER).
Who is sponsoring clinical trial NCT01039324?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01039324's enrollment target sits among peer trials
8,422 18th of 2000 higher than 1,983 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07185828 · 8,286 participants · NA
Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)
- NCT06098079 · 8,600 participants · Phase 4
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
- NCT06435806 · 8,200 participants · NA
Medical Illustration Design Characteristic Evaluation
- NCT06058234 · 8,680 participants
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia